BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 9568171)

  • 21. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Konishi K; Yabushita K; Taguchi T; Ota J; Takashima S; Abe T; Kikkawa N; Yasutomi M; Sowa M; Maehara Y
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
    Stabuc B; Markovic A; Plesnicar A; Cizej TE
    Neoplasma; 2000; 47(4):248-52. PubMed ID: 11043831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma].
    Baur M; Schlappack O; Havelec L; Mader R; Marosi C; Scheithauer W; Dittrich C
    Wien Klin Wochenschr; 1991; 103(11):332-9. PubMed ID: 1858384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Takeda S; Taguchi T; Ohta J; Kurihara M; Abe T; Ohtani T; Yonemura Y; Ohno T; Hirabayashi N; Nakano S
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):903-10. PubMed ID: 7793996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5-Fluorouracil plus low-dose leucovorin in the treatment of advanced colorectal cancer].
    Shida H; Ban K; Matsumoto M; Takei Y; Noda Y; Masuda K; Imanari T; Machida T; Yamamoto T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):249-54. PubMed ID: 8311497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).
    Baumgaertner I; Quinaux E; Khalil A; Louvet C; Buyse M; de Gramont A; André T;
    Clin Colorectal Cancer; 2010 Apr; 9(2):E5-10. PubMed ID: 20378497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
    Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
    Takahashi N; Kunii Y; Ota K
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():447-52. PubMed ID: 8849291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancer.
    de Gramont A; Louvet C; Bennamoun M; Varette C; Demuynck B; Beerblock K; Moreau S; Soubrane D; Mal F; Grangé JD; Zylberait D; Krulik M
    J Infus Chemother; 1996; 6(2):97-101. PubMed ID: 8809658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas.
    Kido Y; Okamura T; Tomikawa M; Yamamoto M; Shiraishi M; Okada Y; Kimura T; Sugimachi K
    Cancer; 1996 Oct; 78(8):1794-7. PubMed ID: 8859194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU.
    Gamelin EC; Danquechin-Dorval EM; Dumesnil YF; Maillart PJ; Goudier MJ; Burtin PC; Delva RG; Lortholary AH; Gesta PH; Larra FG
    Cancer; 1996 Feb; 77(3):441-51. PubMed ID: 8630950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for treatment design: biochemical modulation of 5-fluorouracil by leucovorin.
    Rustum YM; Cao S; Zhang Z
    Cancer J Sci Am; 1998; 4(1):12-8. PubMed ID: 9467039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Carrato A; Fernández-Martos C; Antón-Torres A; Massutí T; Barneto I; García-Conde J; Barón JM; Díaz-Rubio E
    Ann Oncol; 1996 Aug; 7(6):581-5. PubMed ID: 8879371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of chemotherapy in the treatment of advanced colorectal cancer--pilot study of 5-FU by biochemical modulation].
    Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):459-64. PubMed ID: 8678498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of leucovorin and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1001-8. PubMed ID: 7611750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.
    Chiara S; Nobile MT; Vincenti M; Lionetto R; Gozza A; Barzacchi MC; Sanguineti O; Repetto L; Rosso R
    Cancer Chemother Pharmacol; 1998; 42(4):336-40. PubMed ID: 9744780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Dorta J; Blanco E; Fernández-Martos C; Cruz-Hernandez JJ; Carrato A; Gonzalez-Mancha R; García-Conde J; Díaz-Rubio E
    Cancer; 1995 Aug; 76(4):559-63. PubMed ID: 8625147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phase I study of 5-fluorouracil and l-leucovorin].
    Sasaki T; Ota K; Wakui A; Akazawa S; Ogawa M; Ariyoshi Y; Yura J; Inagaki J; Hoshino A; Abe T
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):485-91. PubMed ID: 8452386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.